Microfluidic characterisation reveals broad range of SARS-CoV-2 antibody affinity in human plasma

The clinical outcome of SARS-CoV-2 infections, which can range from asymptomatic to lethal, is crucially shaped by the concentration of antiviral antibodies and by their affinity to their targets. However, the affinity of polyclonal antibody responses in plasma is difficult to measure. Here we used...

Descripción completa

Detalles Bibliográficos
Autores principales: Schneider, Matthias M, Emmenegger, Marc, Xu, Catherine K, Condado Morales, Itzel, Meisl, Georg, Turelli, Priscilla, Zografou, Chryssa, Zimmermann, Manuela R, Frey, Beat M, Fiedler, Sebastian, Denninger, Viola, Jacquat, Raphaël PB, Madrigal, Lidia, Ilsley, Alison, Kosmoliaptsis, Vasilis, Fiegler, Heike, Trono, Didier, Knowles, Tuomas PJ, Aguzzi, Adriano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Life Science Alliance LLC 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645332/
https://www.ncbi.nlm.nih.gov/pubmed/34848436
http://dx.doi.org/10.26508/lsa.202101270

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645332/
https://www.ncbi.nlm.nih.gov/pubmed/34848436
http://dx.doi.org/10.26508/lsa.202101270

Ejemplares similares